Markets

Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher

Fortress Biotech, Inc.FBIO was a big mover last session, as its shares rose almost 21% on the day. The move came after the company reported breakthrough with CAR-T cancer approach. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.95 to $2.43 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Fortress Biotech currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

FORTRESS BIOTEC Price

FORTRESS BIOTEC Price | FORTRESS BIOTEC Quote

A better-ranked stock in the medical-biomedical and genetics space is Arbutus Biopharma Corporation ABUS , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today's most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ARBUTUS BIOPH (ABUS): Free Stock Analysis Report

FORTRESS BIOTEC (FBIO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ABUS FBIO

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More